Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan

被引:47
作者
Lu, SN
Chue, PY
Chen, HC
Wu, MH
Chen, IL
Huang, JF
Wang, JH
Peng, CF
Shih, CH
You, SL
Lu, CF
Chen, CJ
Chang, WY
机构
[1] KAOHSIUNG MED COLL,SCH TECHNOL & MED SCI,KAOHSIUNG,TAIWAN
[2] NATL TAIWAN UNIV,INST EPIDEMIOL,TAIPEI 10764,TAIWAN
[3] PRIMARY HLTH CARE CTR TZUKUAN TOWNSHIP,KAOHSIUNG,TAIWAN
[4] PRIMARY HLTH CARE CTR TAILIAU TOWNSHIP,KAOHSIUNG,TAIWAN
[5] KAOHSIUNG MED COLL HOSP,DEPT INTERNAL MED,KAOHSIUNG,TAIWAN
[6] NATL INST PREVENT MED,DEPT HLTH,TAIPEI 11513,TAIWAN
关键词
hepatitis B virus; hepatitis C virus; hepatocellular carcinoma;
D O I
10.1111/j.1440-1746.1997.tb00482.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In Taiwan, we found two hepatitis B virus (HBV)- and hepatitis C virus (HCV)-endemic townships, Paisha and Tzukuan, with an anti-HCV prevalence of 19 and 37% in men, and 26 and 38% in women, respectively. The hepatitis B surface antigen (HBsAg)-positive rates were 25 and 18%, for men and women in Paisha, and 25 and 22% in Tzukuan, respectively. According to the national death certification database (1982 to 1991), the annual age-adjusted mortality rates per 100 000 population for liver cancer among men and women were 83.0 and 13.8, respectively, in Paisha, and 55.9 and 17.0 in Tzukuan compared with 30.9 and 9.1 in Taiwan as a whole. The male-to-female ratios were 6.0 in Paisha and 3.3 in Tzukuan. Aetiology of 11 cases of hepatocellular carcinoma (HCC) from Paisha and 14 cases from Tzukuan were analysed. All HCC cases from Paisha were HBsAg positive, while 13/14 HCC cases from Tzukuan were anti-HCV positive. The endemic duration of HCV in Tzukuan seemed long enough to induce HCC, but the HCV appeared to be a newly introduced infection in Paisha.
引用
收藏
页码:547 / 550
页数:4
相关论文
共 50 条
[31]   Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma [J].
Hiotis, Spiros P. ;
Rahbari, Nuh N. ;
Villanueva, Gerald A. ;
Klegar, Eunjie ;
Luan, Wei ;
Wang, Qin ;
Yee, Herman T. .
BMC GASTROENTEROLOGY, 2012, 12
[32]   Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population [J].
Kim, Bo Hyun ;
Lim, Young-Suk ;
Kim, Eun-Yang ;
Kong, Hyun-Joo ;
Won, Young-Joo ;
Han, Seungbong ;
Park, Sohee ;
Hwang, Jae Seok .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (02) :475-483
[33]   Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia [J].
Dondog, Bolormaa ;
Lise, Mauro ;
Dondov, Oyunchimeg ;
Baldandorj, Baigal ;
Franceschi, Silvia .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2011, 20 (01) :33-39
[34]   Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam [J].
Nguyen-Dinh, Song-Huy ;
Li, Wei-Feng ;
Liu, Yueh-Wei ;
Wang, Chih-Chi ;
Chen, Yen-Hao ;
Wang, Jing-Houng ;
Hung, Chao-Hung .
VIRUSES-BASEL, 2022, 14 (11)
[35]   Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: Two case reports [J].
Jung K.S. ;
Chun K.H. ;
Choi G.H. ;
Jeon H.M. ;
Shin H.S. ;
Park Y.N. ;
Park J.Y. .
BMC Research Notes, 6 (1)
[36]   Hepatocellular Carcinoma in a Chronic Hepatitis B Patient With Suppressed Viral Replication [J].
Kutlu, Murat ;
Sayin-Kutlu, Selda ;
Dunya-Erdal, Asligul ;
Agladioglu, Kadir .
KLIMIK JOURNAL, 2016, 29 (03) :130-132
[37]   Hepatitis B Viral Loads in Southern African Blacks With Hepatocellular Carcinoma [J].
Viana, Raquel ;
Wang, Renwei ;
Yu, Mimi C. ;
Welschinger, Robert ;
Chen, Chien-Yu ;
Kew, Michael C. .
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) :1525-1530
[38]   Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD [J].
Liu, Chun-Jen ;
Seto, Wai Kay ;
Yu, Ming-Lung .
HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) :897-908
[39]   Hepatocellular carcinoma associated with chronic hepatitis B and C: pathogenesis, treatment and prevention [J].
Roy, KM ;
McMenamin, J .
REVIEWS IN MEDICAL MICROBIOLOGY, 2000, 11 (03) :171-178
[40]   Interferon for preventing and treating hepatocellular carcinoma associated with the hepatitis B and C viruses [J].
Tabor, E .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (05) :297-305